G. Kahlmeter Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,

Defining an extended-spectrum β-lactamase

Gut bacterial microbiota and obesity

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Defining an extended-spectrum β-lactamase

In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages B. Ekinci, A.Y. Coban, A. Birinci, B. Durupinar,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Escherichia coli native valve endocarditis

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

Cephalosporins: a pharmacological update

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton

Elements of design: the knowledge on which we build

S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter

Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions M. Sjölund, S. Bengtsson, J. Bonnedahl,

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

A. Potron, J. Kalpoe, L. Poirel, P. Nordmann

Metagenomics and probiotics

J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W

W.A. Craig Clinical Microbiology and Infection

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Activity of cefepime and carbapenems in experimental pneumonia caused by porin- deficient Klebsiella pneumoniae producing FOX-5 β-lactamase C. Pichardo,

Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China Y. Luo, Y. Wang, L. Ye, J. Yang Clinical.

Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values J. Turnidge, G. Kahlmeter,

A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented.

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

C. Gagliotti, L. Nobilio, M.L. Moro

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories E. Matuschek,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

European recommendations for antimicrobial resistance surveillance

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints G. Kahlmeter Clinical Microbiology and Infection Volume 14, Pages 169-174 (January 2008) DOI: 10.1111/j.1469-0691.2007.01856.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 MIC distributions for wild-type Escherichia coli and Klebsiella pneumoniae for cefotaxime (top), ceftazidime (middle) and cefepime (bottom) from the EUCAST website (http://www.eucast.org), last accessed on 28 December 2006. Epidemiological cut-off values are shown in the lower left corner and the clinical breakpoints in the lower right corner. Clinical Microbiology and Infection 2008 14, 169-174DOI: (10.1111/j.1469-0691.2007.01856.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions